Bain Capital Life Sciences Investors, LLC: NUVL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on NUVL, newest first. How the timeline and the estimate are built.
Bain Capital Life Sciences Investors, LLC held 0 NUVL shares at 2025-09-30 per its 13F-HR filed 2025-11-14.
the latest 13F is the newest step
- period ended2025-09-3013F 0 sharesChange vs previous 13F -1,447,267 shares
13F-HR 0001193125-25-283094 filed by Bain Capital Life Sciences Investors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-06-3013F 1,447,267 sharesChange vs previous 13F 0 shares
13.82% of the 13F portfolio, value $110,426,472.
13F-HR 0000950123-25-008312 filed by Bain Capital Life Sciences Investors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,447,267 sharesChange vs previous 13F 0 shares
15.19% of the 13F portfolio, value $102,640,176.
13F-HR 0000950123-25-005465 filed by Bain Capital Life Sciences Investors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,447,267 sharesChange vs previous 13F -1,250,000 shares
13.33% of the 13F portfolio, value $113,292,061.
13F-HR 0000950123-25-002317 filed by Bain Capital Life Sciences Investors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 2,697,267 sharesChange vs previous 13F not available
28.71% of the 13F portfolio, value $275,930,414.
13F-HR 0000950123-24-011417 filed by Bain Capital Life Sciences Investors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).